IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Regeneron Pharmaceuticals, Inc.

Q1 2026 Holdings

Filed 2026-05-08 | 2 holdings | $47.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Intellia Therapeutics, Inc.(NTLA)Common Stock45826J105$47.5M3,702,99599.1%
Adicet Bio, Inc.(TORCEUR)Common Stock007002108$412.1K60,5110.9%